PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Insurance Benefits”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,495 records · Page 83Linked to original sources

The economic impact of bipolar disorder in an employed population from an employer perspective.

OBJECTIVE: To determine the economic impact of bipolar disorder on health benefit costs and health-related work absences from an employer perspective. METHOD: Data on health benefit costs and health-related absences during 2001 and 2002 were retrieved from a database and retrospectively examined. Regression modeling measured the cost differences while controlling for potentially confounding factors. The study population consisted of employees at multiple large employers who were widely dispersed throughout the United States. These employees were grouped into 2 cohorts: (1) employees with a bipolar disorder diagnosis (primary, secondary, or tertiary ICD-9 code of 296.0x, 296.1x, 296.4x, 296.5x, 296.6x, 296.7x, or 296.8x) in 2001 and (2) employees with no bipolar disorder diagnosis during 2001 or 2002 (comparison cohort). Specific outcome measures included annual health benefit claim costs and salary-replacement payments for the following employee health benefits: health care insurance, prescription drug, sick leave, short- and long-term disability, and workers' compensation. Additional outcome measures included annual absence days due to workers' compensation, short- and long-term disability, and sick leave (separately). RESULTS: The analysis identified 761 employees (0.3%) with bipolar disorder and 229,145 eligible employees without bipolar disorder. Employees with bipolar disorder annually cost $6836 more than employees without bipolar disorder (p < .05) and were more costly in every health benefit cost category. Employees with bipolar disorder missed an average of 18.9 workdays annually, while employees without bipolar disorder missed 7.4 days annually (p < .05). CONCLUSION: The impact of bipolar disorder can be costly in the workplace, leading to increased health benefit costs and increased absenteeism.

Absenteeism↗

Public opinion's tilt against private enterprise.

Drawing on hundreds of identically worded questions, this DataWatch finds that Americans now feel genuine concern for the health status of other people. This is a dramatic development in a country that has encouraged individuals to isolate themselves. The second finding is that necessity has pushed Americans into grudgingly accepting government taxation and regulation as the most feasible way to provide what is by now an expected benefit: secure access to essential health care. Evidence of Americans' concerns and of the tilt away from laissez-faire commitments challenges two of the most sacred conventional assumptions about public opinion in the United States.

Health Care Reform↗

Using cost-effectiveness analysis to define a breast cancer benefits package for the uninsured.

OBJECTIVES: In 1999, California was considering legislation to fund breast cancer treatment for its uninsured. We sought to define the most cost-effective breast cancer benefits package in order to inform this debate. METHODS: We use cost-effectiveness analysis to calculate the additional costs and benefits of various adjuvant therapy strategies, radiation after breast conserving surgery, and reconstruction compared to those of surgery alone in order to define the most cost-effective breast cancer benefits package for uninsured women. RESULTS: Using cost-effectiveness analysis, we define a Minimum Breast Cancer Benefits Package that includes only the most cost-effective life-saving breast cancer treatments. To provide these benefits for an estimated 550 breast cancer patients will cost $10,200,000. We present two options that each cost an additional $1,700,000 - to expand the benefits to these patients to include post-mastectomy radiation and breast reconstruction; or to provide the Minimum Package to an additional 93 uninsured women. CONCLUSIONS: California legislators must decide whether to offer comprehensive benefits to a limited number of breast cancer patients or to provide only the most life-saving treatments to a greater number of women.

Breast Neoplasms↗

New HEDIS means more information about HMOs.

The latest version of the Health Plan Employer Data and Information Set (HEDIS) is a standardized set of measures to provide health care purchasers and consumers with the information needed to compare the performance of different managed care plans. HEDIS 3.0 combines the last two versions and extends the use to an HMO's Medicare members. The 71 measures are spread over eight topics of interest to purchasers and consumers.

Consumer Behavior↗